͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ   ͏ β€Œ  ­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­ Β­

5 more years


We are pleased to announce that the National Institute of General Medical Sciences, NIH, has awarded a five-year, $24.9 million grant, marking the renewal of the Alliance for Clinical & Translational Research (2025–2030).

Alliance services



Facilities and Resources





Clinical Research Units, labs, volunteer registry, and biorepositories

Upcoming Events



Are you a faculty member or researcher interested in improving your manuscript writing and reviewer skills?

CAPAC 2026 Summer Program

Each year, CAPAC recruits participants from various academic programs for a mentored research experience in basic, clinical, or population-based cancer research.


The sixth cohort will take place from May 26 to July 31, 2026.

Application period: Opens October 31, 2025 | Deadline: January 23, 2026



Rare variants in PRKCI cause Van der Woude syndrome and other features of peridermopathy

Kelsey Robinson, Sunil K. Singh, Rachel B. Walkup, Dorelle V. Fawwal, Kendra M. Vilfort, Amanda Koloskee, Azeez Fashina, Wasiu Lanre Adeyemo, Terri H. Beaty, Azeez Butali, Carmen J. BuxΓ³, Wendy K. Chung, David J. Cutler, Michael P. Epstein, Brooklynn Gasser, Lord J.J. Gowans, Jacqueline T. Hecht, Anuj Mankad, Lina Moreno Uribe, Daryl A. Scott, Gary M. Shaw, Mary Ann Thomas, Seth M. Weinberg, Eric C. Liao, Harrison Brand, Mary L. Marazita, Robert J. Lipinski, Jeffrey C. Murray, Robert A. Cornell, Elizabeth J. Leslie-Clarkson



Van der Woude syndrome (VWS) is an autosomal dominant disorder characterized by lower lip pits and orofacial clefts (OFCs). With a prevalence of ∼1 in 35,000 live births, it is the most common form of syndromic clefting. Most VWS is attributed to… Read More